Aspinwall Lisa G, Taber Jennifer M, Kohlmann Wendy, Leaf Samantha L, Leachman Sancy A
Department of Psychology, University of Utah, 380 South 1530 East, Room 502, Salt Lake City, UT, 84112-0251, USA,
J Genet Couns. 2014 Jun;23(3):421-37. doi: 10.1007/s10897-013-9676-1. Epub 2013 Dec 10.
A major goal of predictive genetic testing is to alert people to their risk before illness onset; however, little is known about how risk perceptions change following genetic testing and whether information is recalled accurately over time. In the United States, a CDKN2A/p16 mutation confers 76 % lifetime risk of melanoma. Following genetic counseling and test reporting, subjective risk estimates and recall of counselor-provided risk estimates were assessed 5 times over the next 2 years among 60 adult members of 2 extended CDKN2A/p16 kindreds. No sustained changes from baseline in risk perceptions were reported. Unaffected carriers (n = 15) consistently reported significantly lower subjective risk estimates (46 %) than they were actually given (76 %, p < 0.001) or recalled having been given (60 %, p < 0.001). Noncarriers' (n = 27) risk estimates decreased following results disclosure, but rebounded, with both subjective and recalled estimates subsequently exceeding what they were told by the counselor (both ps < 0.001). Affected carriers' (n = 18) risk estimates for developing a new melanoma corresponded well to counselor-provided information (p = 0.362). For all 3 patient groups, results were consistent across multiple risk measures and remained similar when demographic, phenotypic, and baseline behavioral contributors to melanoma risk were statistically controlled. These findings are consistent with other studies of risk perception, but additional studies of more diverse populations are needed to understand the reasons behind both the persistence of initial risk estimates and their divergence from information provided by the counselor during genetic counseling. Additionally, determining whether holding subjective risk perceptions that differ from counselor-provided information ultimately affects adherence to management recommendations will help guide the presentation of risk information in genetic counseling practice.
预测性基因检测的一个主要目标是在疾病发作前提醒人们注意自身风险;然而,对于基因检测后风险认知如何变化以及随着时间推移信息是否能被准确回忆,我们知之甚少。在美国,CDKN2A/p16基因突变会使患黑色素瘤的终生风险达到76%。在对两个CDKN2A/p16基因扩展家族的60名成年成员进行基因咨询和检测报告后,在接下来的2年里对他们进行了5次主观风险估计以及对咨询师提供的风险估计的回忆情况评估。结果显示,风险认知与基线相比没有持续变化。未受影响的携带者(n = 15)一直报告的主观风险估计(46%)显著低于实际告知他们的风险(76%,p < 0.001)或回忆中被告知的风险(60%,p < 0.001)。非携带者(n = 27)在结果披露后风险估计下降,但随后反弹,主观和回忆的估计都超过了咨询师告知他们的风险(p值均 < 0.001)。受影响的携带者(n = 18)对新发黑色素瘤的风险估计与咨询师提供的信息相当吻合(p = 0.362)。对于所有这三组患者,在多种风险测量指标上结果都是一致的,并且在对黑色素瘤风险的人口统计学、表型和基线行为因素进行统计学控制时,结果仍然相似。这些发现与其他关于风险认知的研究一致,但需要对更多样化的人群进行进一步研究,以了解初始风险估计持续存在以及与基因咨询期间咨询师提供的信息产生差异的原因。此外,确定持有与咨询师提供的信息不同的主观风险认知最终是否会影响对管理建议的依从性,将有助于指导基因咨询实践中风险信息的呈现。